Guidant COMPANION Results Support Contak CD Mortality Benefit

Guidant's Contak CD cardiac resynchronization therapy pacemaker/ICD demonstrated a 40% reduction in all-cause mortality compared with optimum medical therapy, data from the firm-sponsored COMPANION study show